IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,646,753 | +1123.6% | 248,755 | +1109.8% | 0.04% | +950.0% |
| Q1 2023 | $216,312 | +116825.4% | 20,562 | +38.0% | 0.00% | +33.3% |
| Q4 2022 | $185 | -99.9% | 14,903 | -0.6% | 0.00% | 0.0% |
| Q3 2022 | $155,000 | -10.4% | 14,989 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $173,000 | -8.0% | 14,989 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $188,000 | -12.1% | 14,974 | -18.5% | 0.00% | 0.0% |
| Q4 2021 | $214,000 | +7.5% | 18,383 | +20.9% | 0.00% | 0.0% |
| Q3 2021 | $199,000 | +33.6% | 15,201 | +31.7% | 0.00% | +50.0% |
| Q2 2021 | $149,000 | 0.0% | 11,544 | -13.4% | 0.00% | 0.0% |
| Q1 2021 | $149,000 | -27.0% | 13,337 | -25.6% | 0.00% | 0.0% |
| Q4 2020 | $204,000 | – | 17,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |